Adult Oral Phenytoin (Eptoin) Dosing
For adults requiring oral phenytoin loading, administer 15-20 mg/kg divided into 3 doses given 2-4 hours apart (typically 1000 mg total for a 70 kg patient as 400 mg, 300 mg, 300 mg), followed by maintenance dosing of 300 mg daily or 100 mg three times daily starting 12-24 hours after the loading dose. 1
Loading Dose Regimens
Oral Loading (When IV Not Required):
- Dose: 15-20 mg/kg total loading dose 1
- Administration: Divide into 3 doses given 2-4 hours apart to minimize gastrointestinal upset 2
- Example for 70 kg patient: 400 mg, then 300 mg, then 300 mg over 6-8 hours
- Time to therapeutic levels:
Key advantage of divided oral loading: Studies demonstrate that 66% of patients achieve therapeutic levels within 24 hours, with virtually no serious adverse reactions when using the divided-dose approach 2. Single large doses (1000 mg) can cause significant GI upset, while divided dosing eliminates this problem 2.
Maintenance Dosing
Standard Maintenance:
- Typical dose: 300 mg once daily OR 100 mg three times daily 1
- Range: 200-700 mg/day depending on individual metabolism 2
- Timing: Begin 12-24 hours after completing loading dose 1
Important pharmacokinetic consideration: Without a loading dose, it takes 3-7 days to reach therapeutic steady-state levels with maintenance dosing alone 2. Some patients may never achieve therapeutic levels (≥10 mcg/mL) on standard 300 mg daily dosing and require dose adjustment 2.
Critical Dosing Adjustments
Elderly Patients:
Renal/Hepatic Impairment or Hypoalbuminemia:
- Monitor unbound (free) phenytoin levels, not total levels 1
- Increased fraction of unbound drug requires dose adjustment based on free levels 1
Pregnancy:
- Phenytoin clearance increases during pregnancy, peaking in third trimester 1
- Requires periodic monitoring and dose increases during pregnancy
- Monitor unbound phenytoin concentrations 1
- Postpartum: restore original pre-pregnancy dose 1
Therapeutic Monitoring
Target Levels:
Monitoring Strategy:
- Trough levels: Obtain just before next scheduled dose to assess therapeutic range 1
- Peak levels: Obtained at expected peak to identify threshold for dose-related toxicity 1
- Follow-up monitoring essential after ED discharge, even if levels not checked before discharge 2
Common Pitfalls to Avoid
Non-weight-based dosing: Many older studies used fixed 1000 mg doses regardless of weight, leading to subtherapeutic or toxic levels 2. Always calculate based on actual body weight.
Switching between formulations: ~8% difference in drug content between sodium salt and free acid forms requires dose adjustment and monitoring 1
Monitoring total levels in special populations: In renal/hepatic disease or hypoalbuminemia, total levels are misleading—must monitor free (unbound) levels 1
Dose adjustments: Due to saturable (Michaelis-Menten) kinetics, small dose changes (25-50 mg) can cause large changes in serum levels once concentrations reach 5-10 mcg/mL 4. Adjust cautiously in 25-50 mg increments when near therapeutic range.
Drug interactions: Phenytoin is both a substrate and potent inducer of CYP2C9 and CYP2C19 1. Multiple drug-drug and drug-food interactions possible 5.
Dose-Related Adverse Effects
Common side effects include ataxia, nystagmus, tremor, and somnolence 2. These are dose-dependent and typically occur when levels exceed therapeutic range. Divided oral loading minimizes GI upset compared to single large doses 2.